ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,524Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 2456

$902K Total Retail Price of All Prescriptions

Rank: 54 out of 2456

533 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 14,824 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 695 639 1 1
SIMVASTATIN 671 550 2 2
LEVOTHYROXINE SODIUM 598 523 3 4
OMEPRAZOLE 484 328 4 3
WARFARIN SODIUM 467 432 5 9
AMLODIPINE BESYLATE 462 442 6 5
ATENOLOL 451 387 7 6
METOPROLOL TARTRATE 445 401 8 10
POTASSIUM CHLORIDE 434 368 9 33
FUROSEMIDE 398 387 10 8
ATORVASTATIN CALCIUM 382 313 11 12
METOPROLOL SUCCINATE 315 283 12 13
TRAZODONE HCL 307 290 13 17
PRAVASTATIN SODIUM 292 222 14 15
LOSARTAN POTASSIUM 272 263 15 18
METFORMIN HCL 267 227 16 11
HYDROCHLOROTHIAZIDE 264 209 17 7
CITALOPRAM HBR 260 233 18 14
ISOSORBIDE MONONITRATE ER 222 214 19 48
MIRTAZAPINE 220 181 20 29
KLOR-CON M20 219 159 21 69
GABAPENTIN 207 171 22 16
RANITIDINE HCL 198 151 23 31
ADVAIR DISKUS 186 175 24 36
ALENDRONATE SODIUM 168 117 25 19
ALLOPURINOL 160 135 26 27
FLUOXETINE HCL 154 149 27 45
TRAMADOL HCL 152 137 28 24
FLUTICASONE PROPIONATE 148 122 29 30
SERTRALINE HCL 144 97 30 21
NAMENDA 140 129 31 42
TAMIFLU 137 136 32 217
DIOVAN 131 131 33 26
TAMSULOSIN HCL 130 130 34 32
NIFEDIPINE ER 129 113 35 61
HYDROCODONE-ACETAMINOPHEN 119 97 S3 36 20
RISPERIDONE 118 104 37 50
SPIRIVA 116 107 38 43
OLANZAPINE 112 95 39 57
DONEPEZIL HCL 112 112 39 23
SPIRONOLACTONE 106 96 41 73
LANTUS 105 102 42 44
LACTULOSE 103 68 43 88
LOVASTATIN 100 90 44 34
PROAIR HFA 99 66 45 22
ESCITALOPRAM OXALATE 89 89 46 116
LIPITOR 88 73 47 63
PREDNISONE 86 73 48 39
OXYCODONE HCL 86 72 S2 48 38
ZOLPIDEM TARTRATE 84 67 50 28
DIGOXIN 78 74 51 49
FENOFIBRATE 77 51 52 68
CYMBALTA 73 73 53 65
CARVEDILOL 72 72 54 54
LIDODERM 72 70 54 58
PAROXETINE HCL 71 56 56 56
LANTUS SOLOSTAR 70 42 57 136
FENTANYL 68 62 S2 58 115
BUPROPION HCL SR 67 47 59 119
CIPROFLOXACIN HCL 66 63 60 87
POLYETHYLENE GLYCOL 3350 66 39 60 64
QUETIAPINE FUMARATE 66 53 60 47
CARBIDOPA-LEVODOPA 64 64 63 82
NYSTATIN 63 58 64 99
PANTOPRAZOLE SODIUM 63 43 64 37
PLAVIX 62 62 66 79
OXYBUTYNIN CHLORIDE ER 61 47 67 94
GLIPIZIDE 59 54 68 46
GLYBURIDE 59 59 R 68 40
GEMFIBROZIL 59 42 68 93
INSULIN SYRINGE 58 48 71 72
DOXAZOSIN MESYLATE 56 43 72 71
PEN NEEDLE 56 34 72 150
CLOPIDOGREL 54 54 74 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 52 74 41
JANUVIA 53 53 76 81
DOXYCYCLINE HYCLATE 51 45 77 166
IBUPROFEN 51 43 77 52
VENLAFAXINE HCL ER 51 39 77 92
LIDOCAINE HCL 50 49 80 262
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.